NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES, OR FOR PUBLICATION, PUBLICATION, DISTRIBUTION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR IN THE UNITED STATES.
TORONTO – Hempsana Holdings Ltd. (the “Company” or “Hempsana”) is pleased to announce that the Company has received approval from Health Canada to amend its cannabis license to allow the sale of cannabis extracts, beverages, edibles and topical products. The amended license will allow Hempsana to supply and sell finished cannabis products directly to provincial distributors and other authorized Canadian retail delivery channels.
Randy Ko, Hempsana Co-Founder and CEO, says: “The ability to sell Cannabis 2.0 products in the Canadian market through our cannabis sales license is a significant milestone as it will enhance our source of income through the delivery of high quality cannabis derivatives in API- Quality for our B2B also expands customers. It also gives us a unique opportunity to leverage our rare cannabinoid manufacturing capabilities if we want to incorporate cannabinoids such as CBN and CBG into specialized high quality API products that consumers can enjoy. ”
About Hempsana Holdings Ltd.
The company’s business includes the manufacture of cannabis derivatives and the manufacture of cannabis extracts for use in finished products, including extracts, beverages, edibles and topical creams. Hempsana’s Health Canada Standard Processing Licensed and EU GMP compliant facility gives the company access to wholesale and retail channels in Canada and internationally.
The securities listed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the “US Securities Act”) or the securities laws of any state and may not be offered or sold in the United States or to or for the account of or for the benefit of US persons without registration or an applicable exemption from the registration requirements of the US Securities Act and applicable US securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in the United States, nor will any sale of such securities be made in any jurisdiction in which such offer, solicitation or sale is unlawful were.
This press release contains forward-looking statements and forward-looking information within the meaning of applicable Canadian and US securities laws. The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “ongoing”, “can”, “will”, “project”, “should”, “believe”, “ Plans, ”“ intends ”and similar expressions are intended to identify forward-looking information or statements. In particular, and without limitation, this press release contains forward-looking statements and information about the business and operations of the company. The forward-looking statements and information are based on certain key expectations and assumptions made by management, including expectations and assumptions about the company. Although the company’s management believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on any forward-looking statements and information. There is no guarantee that they will prove to be correct. By its very nature, such forward-looking information is subject to various risks and uncertainties that could cause actual results and expectations to differ materially from those anticipated or expressed. These risks and uncertainties include, among other things, general economic conditions and the state of the regulatory environment. For more details on the risks to which the company is exposed, please see the company’s public records on SEDAR at www.sedar.com. Readers are cautioned not to place undue reliance on this forward-looking information as of the date of this publication and not to use this forward-looking information for any purpose other than its intended purpose. The company’s management assumes no obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or for other reasons, unless this is required by law.
Director and Chief Executive Officer
T: (647) 255-8849